Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 10/2014

01-10-2014 | Letter to the editor

Response to “Safety profile of intravenous patient-controlled analgesia for breathrough pain in cancer patients: a case series study”

Author: Andrew Davies

Published in: Supportive Care in Cancer | Issue 10/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Sousa AM, de Santana Neto J, Guimaraes GM, Cascudo GM, Neto JO, Ashmawi HA (2014) Safety profile of intravenous patient-controlled analgesia for breakthrough pain in cancer patients: a case series. Support Care Cancer 22:795–801PubMedCrossRef
2.
Davies AN, Dickman A, Reid C, Stevens A-M, Zeppetella G (2009) The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 13:331–338PubMedCrossRef
3.
Haugen DF, Hjermstad MJ, Hagen N, Caraceni A, Kaasa S (2010) Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain 149:476–482PubMedCrossRef
4.
Davies A, Buchanan A, Zeppetella G, Porta-Sales J, Likar R, Weismayr W et al (2013) Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manag 46:619–628CrossRef
Metadata
Title
Response to “Safety profile of intravenous patient-controlled analgesia for breathrough pain in cancer patients: a case series study”
Author
Andrew Davies
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 10/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2283-3

Other articles of this Issue 10/2014

Supportive Care in Cancer 10/2014 Go to the issue

Original Article

Correlates of resistance training in post-treatment breast cancer survivors

Original Article

Impact of dose modification on intravenous Bortezomib-induced peripheral neuropathy in multiple myeloma patients

Original Article

Psychological distress and quality of life of palliative cancer patients and their caring relatives during home care

Original Article

Predictors of sexual well-being after endometrial cancer: results of a national self-report survey

Original Article

Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients

Original Article

Technological preferences of aging cancer patients for delivery services and devices to solve drug-related problems in oncology
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits